TEVA(TEVA) - 2024 Q2 - Earnings Call Presentation

July 31, 2024 Non-GAAP Financial Measures 2 | tewa Deliver on growth engines • UZEDY® on track to reach 2024 revenue outlook • Duvakitug (Anti-TL1A) timeline acceleration: top-line results expected Q4'24 with full data in 2025 • Generics growth across all geographies • Teva api is back to growth, up 5% in Q2'24 Quarterly Revenue Growth vs. previous year +4% Q1 2023 Q2 2024Revenues Non-GAAP EPS Net Debt / EBITDA Q2 2024 Strong Performance Raising 2024 revenues outlook from ~$1.5B to ~$1.6B TRx Growth +30% AU ...